Cannabinoid Therapies in Less-Common Disorders: Clinical Evidence and Formulation Strategies. [PDF]
DiseasesAfonso S +6 more
europepmc +1 more source
Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. [PDF]
Pharmaceuticals (Basel)Marques BL +5 more
europepmc +1 more source
Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD. [PDF]
Genes (Basel)Kalak M +3 more
europepmc +1 more source
Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics. [PDF]
NeurotherapeuticsPieper AA, Lee FS.
europepmc +1 more source
Integrated Computational Investigation of <i>Cannabis sativa</i> Phytoconstituents as Putative Multi-Target Inhibitors in Skin Cancer: A Molecular Docking, Dynamics, and ADMET Profiling Study. [PDF]
Pharmaceuticals (Basel)Bouamri LE +7 more
europepmc +1 more source
Allosteric Modulation of Cannabinoid Type 1 Receptor by ZCZ011: Integration of In Vitro Pharmacology and Molecular Dynamics Simulation. [PDF]
ACS Bio Med Chem AuYadav TC +8 more
europepmc +1 more source
The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas. [PDF]
Int J Mol SciSerefko A +4 more
europepmc +1 more source
Protective effect of cannabinoid type II receptor ligand on bleomycin-induced pulmonary fibrosis in mice. [PDF]
PLoS OneCao C +9 more
europepmc +1 more source
Levodopa-induced dyskinesia in Parkinson's disease: an updated review of pharmacological treatments. [PDF]
Front Aging NeurosciChen F, Zhou C.
europepmc +1 more source